Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Designed antiviral proteins inhibit SARS-CoV-2 in the lab

worldpharmanewsSeptember 17, 2020

Tag: SARS-CoV-2 , COVID-19 , LCB1

PharmaSources Customer Service